Global Radiopharmaceuticals Sales Market Report 2021

    • ID: AR3033446
    • 01 April, 2021
    • Other
    • Region: Global
    • 146 Pages
    • QYResearch

    1 Radiopharmaceuticals Market Overview

    • 1.1 Radiopharmaceuticals Product Scope
    • 1.2 Radiopharmaceuticals Segment by Type
      • 1.2.1 Global Radiopharmaceuticals Sales by Type (2016 & 2021 & 2027)
      • 1.2.2 Diagnostic Radioisotopes
      • 1.2.3 Therapeutic Radioisotopes
    • 1.3 Radiopharmaceuticals Segment by Application
      • 1.3.1 Global Radiopharmaceuticals Sales Comparison by Application (2016 & 2021 & 2027)
      • 1.3.2 Oncology
      • 1.3.3 Cardiology
      • 1.3.4 Other
    • 1.4 Radiopharmaceuticals Market Estimates and Forecasts (2016-2027)
      • 1.4.1 Global Radiopharmaceuticals Market Size in Value Growth Rate (2016-2027)
      • 1.4.2 Global Radiopharmaceuticals Market Size in Volume Growth Rate (2016-2027)
      • 1.4.3 Global Radiopharmaceuticals Price Trends (2016-2027)

    2 Radiopharmaceuticals Estimates and Forecasts by Region

    • 2.1 Global Radiopharmaceuticals Market Size by Region: 2016 VS 2021 VS 2027
    • 2.2 Global Radiopharmaceuticals Retrospective Market Scenario by Region (2016-2021)
      • 2.2.1 Global Radiopharmaceuticals Sales Market Share by Region (2016-2021)
      • 2.2.2 Global Radiopharmaceuticals Revenue Market Share by Region (2016-2021)
    • 2.3 Global Radiopharmaceuticals Market Estimates and Forecasts by Region (2022-2027)
      • 2.3.1 Global Radiopharmaceuticals Sales Estimates and Forecasts by Region (2022-2027)
      • 2.3.2 Global Radiopharmaceuticals Revenue Forecast by Region (2022-2027)
    • 2.4 Geographic Market Analysis: Market Facts & Figures
      • 2.4.1 North America Radiopharmaceuticals Estimates and Projections (2016-2027)
      • 2.4.2 Europe Radiopharmaceuticals Estimates and Projections (2016-2027)
      • 2.4.3 China Radiopharmaceuticals Estimates and Projections (2016-2027)
      • 2.4.4 Japan Radiopharmaceuticals Estimates and Projections (2016-2027)
      • 2.4.5 Southeast Asia Radiopharmaceuticals Estimates and Projections (2016-2027)
      • 2.4.6 India Radiopharmaceuticals Estimates and Projections (2016-2027)

    3 Global Radiopharmaceuticals Competition Landscape by Players

    • 3.1 Global Top Radiopharmaceuticals Players by Sales (2016-2021)
    • 3.2 Global Top Radiopharmaceuticals Players by Revenue (2016-2021)
    • 3.3 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2020)
    • 3.4 Global Radiopharmaceuticals Average Price by Company (2016-2021)
    • 3.5 Manufacturers Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
    • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Global Radiopharmaceuticals Market Size by Type

    • 4.1 Global Radiopharmaceuticals Historic Market Review by Type (2016-2021)
      • 4.1.1 Global Radiopharmaceuticals Sales Market Share by Type (2016-2021)
      • 4.1.2 Global Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
      • 4.1.3 Global Radiopharmaceuticals Price by Type (2016-2021)
    • 4.2 Global Radiopharmaceuticals Market Estimates and Forecasts by Type (2022-2027)
      • 4.2.1 Global Radiopharmaceuticals Sales Forecast by Type (2022-2027)
      • 4.2.2 Global Radiopharmaceuticals Revenue Forecast by Type (2022-2027)
      • 4.2.3 Global Radiopharmaceuticals Price Forecast by Type (2022-2027)

    5 Global Radiopharmaceuticals Market Size by Application

    • 5.1 Global Radiopharmaceuticals Historic Market Review by Application (2016-2021)
      • 5.1.1 Global Radiopharmaceuticals Sales Market Share by Application (2016-2021)
      • 5.1.2 Global Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
      • 5.1.3 Global Radiopharmaceuticals Price by Application (2016-2021)
    • 5.2 Global Radiopharmaceuticals Market Estimates and Forecasts by Application (2022-2027)
      • 5.2.1 Global Radiopharmaceuticals Sales Forecast by Application (2022-2027)
      • 5.2.2 Global Radiopharmaceuticals Revenue Forecast by Application (2022-2027)
      • 5.2.3 Global Radiopharmaceuticals Price Forecast by Application (2022-2027)

    6 North America Radiopharmaceuticals Market Facts & Figures

    • 6.1 North America Radiopharmaceuticals Sales by Company
      • 6.1.1 North America Radiopharmaceuticals Sales by Company (2016-2021)
      • 6.1.2 North America Radiopharmaceuticals Revenue by Company (2016-2021)
    • 6.2 North America Radiopharmaceuticals Sales Breakdown by Type
      • 6.2.1 North America Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
      • 6.2.2 North America Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
    • 6.3 North America Radiopharmaceuticals Sales Breakdown by Application
      • 6.3.1 North America Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
      • 6.3.2 North America Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

    7 Europe Radiopharmaceuticals Market Facts & Figures

    • 7.1 Europe Radiopharmaceuticals Sales by Company
      • 7.1.1 Europe Radiopharmaceuticals Sales by Company (2016-2021)
      • 7.1.2 Europe Radiopharmaceuticals Revenue by Company (2016-2021)
    • 7.2 Europe Radiopharmaceuticals Sales Breakdown by Type
      • 7.2.1 Europe Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
      • 7.2.2 Europe Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
    • 7.3 Europe Radiopharmaceuticals Sales Breakdown by Application
      • 7.3.1 Europe 146 Sales Breakdown by Application (2016-2021)
      • 7.3.2 Europe 146 Sales Breakdown by Application (2022-2027)

    8 China Radiopharmaceuticals Market Facts & Figures

    • 8.1 China Radiopharmaceuticals Sales by Company
      • 8.1.1 China Radiopharmaceuticals Sales by Company (2016-2021)
      • 8.1.2 China Radiopharmaceuticals Revenue by Company (2016-2021)
    • 8.2 China Radiopharmaceuticals Sales Breakdown by Type
      • 8.2.1 China Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
      • 8.2.2 China Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
    • 8.3 China Radiopharmaceuticals Sales Breakdown by Application
      • 8.3.1 China 314 Sales Breakdown by Application (2016-2021)
      • 8.3.2 China 314 Sales Breakdown by Application (2022-2027)

    9 Japan Radiopharmaceuticals Market Facts & Figures

    • 9.1 Japan Radiopharmaceuticals Sales by Company
      • 9.1.1 Japan Radiopharmaceuticals Sales by Company (2016-2021)
      • 9.1.2 Japan Radiopharmaceuticals Revenue by Company (2016-2021)
    • 9.2 Japan Radiopharmaceuticals Sales Breakdown by Type
      • 9.2.1 Japan Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
      • 9.2.2 Japan Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
    • 9.3 Japan Radiopharmaceuticals Sales Breakdown by Application
      • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
      • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

    10 Southeast Asia Radiopharmaceuticals Market Facts & Figures

    • 10.1 Southeast Asia Radiopharmaceuticals Sales by Company
      • 10.1.1 Southeast Asia Radiopharmaceuticals Sales by Company (2016-2021)
      • 10.1.2 Southeast Asia Radiopharmaceuticals Revenue by Company (2016-2021)
    • 10.2 Southeast Asia Radiopharmaceuticals Sales Breakdown by Type
      • 10.2.1 Southeast Asia Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
      • 10.2.2 Southeast Asia Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
    • 10.3 Southeast Asia Radiopharmaceuticals Sales Breakdown by Application
      • 10.3.1 Southeast Asia K Dose Sales Breakdown by Application (2016-2021)
      • 10.3.2 Southeast Asia K Dose Sales Breakdown by Application (2022-2027)

    11 India Radiopharmaceuticals Market Facts & Figures

    • 11.1 India Radiopharmaceuticals Sales by Company
      • 11.1.1 India Radiopharmaceuticals Sales by Company (2016-2021)
      • 11.1.2 India Radiopharmaceuticals Revenue by Company (2016-2021)
    • 11.2 India Radiopharmaceuticals Sales Breakdown by Type
      • 11.2.1 India Radiopharmaceuticals Sales Breakdown by Type (2016-2021)
      • 11.2.2 India Radiopharmaceuticals Sales Breakdown by Type (2022-2027)
    • 11.3 India Radiopharmaceuticals Sales Breakdown by Application
      • 11.3.1 India Radiopharmaceuticals Sales Breakdown by Application (2016-2021)
      • 11.3.2 India Radiopharmaceuticals Sales Breakdown by Application (2022-2027)

    12 Company Profiles and Key Figures in Radiopharmaceuticals Business

    • 12.1 Bracco Imaging
      • 12.1.1 Bracco Imaging Corporation Information
      • 12.1.2 Bracco Imaging Business Overview
      • 12.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.1.4 Bracco Imaging Radiopharmaceuticals Products Offered
      • 12.1.5 Bracco Imaging Recent Development
    • 12.2 Bayer
      • 12.2.1 Bayer Corporation Information
      • 12.2.2 Bayer Business Overview
      • 12.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.2.4 Bayer Radiopharmaceuticals Products Offered
      • 12.2.5 Bayer Recent Development
    • 12.3 Mallinckrodt
      • 12.3.1 Mallinckrodt Corporation Information
      • 12.3.2 Mallinckrodt Business Overview
      • 12.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.3.4 Mallinckrodt Radiopharmaceuticals Products Offered
      • 12.3.5 Mallinckrodt Recent Development
    • 12.4 Nordion
      • 12.4.1 Nordion Corporation Information
      • 12.4.2 Nordion Business Overview
      • 12.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.4.4 Nordion Radiopharmaceuticals Products Offered
      • 12.4.5 Nordion Recent Development
    • 12.5 Triad Isotopes
      • 12.5.1 Triad Isotopes Corporation Information
      • 12.5.2 Triad Isotopes Business Overview
      • 12.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.5.4 Triad Isotopes Radiopharmaceuticals Products Offered
      • 12.5.5 Triad Isotopes Recent Development
    • 12.6 Lantheus
      • 12.6.1 Lantheus Corporation Information
      • 12.6.2 Lantheus Business Overview
      • 12.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.6.4 Lantheus Radiopharmaceuticals Products Offered
      • 12.6.5 Lantheus Recent Development
    • 12.7 IBA Group
      • 12.7.1 IBA Group Corporation Information
      • 12.7.2 IBA Group Business Overview
      • 12.7.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.7.4 IBA Group Radiopharmaceuticals Products Offered
      • 12.7.5 IBA Group Recent Development
    • 12.8 GE Healthcare
      • 12.8.1 GE Healthcare Corporation Information
      • 12.8.2 GE Healthcare Business Overview
      • 12.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.8.4 GE Healthcare Radiopharmaceuticals Products Offered
      • 12.8.5 GE Healthcare Recent Development
    • 12.9 China Isotope & Radiation
      • 12.9.1 China Isotope & Radiation Corporation Information
      • 12.9.2 China Isotope & Radiation Business Overview
      • 12.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.9.4 China Isotope & Radiation Radiopharmaceuticals Products Offered
      • 12.9.5 China Isotope & Radiation Recent Development
    • 12.10 Jubilant Pharma
      • 12.10.1 Jubilant Pharma Corporation Information
      • 12.10.2 Jubilant Pharma Business Overview
      • 12.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.10.4 Jubilant Pharma Radiopharmaceuticals Products Offered
      • 12.10.5 Jubilant Pharma Recent Development
    • 12.11 Eli Lilly
      • 12.11.1 Eli Lilly Corporation Information
      • 12.11.2 Eli Lilly Business Overview
      • 12.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.11.4 Eli Lilly Radiopharmaceuticals Products Offered
      • 12.11.5 Eli Lilly Recent Development
    • 12.12 Advanced Accelerator Applications
      • 12.12.1 Advanced Accelerator Applications Corporation Information
      • 12.12.2 Advanced Accelerator Applications Business Overview
      • 12.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.12.4 Advanced Accelerator Applications Radiopharmaceuticals Products Offered
      • 12.12.5 Advanced Accelerator Applications Recent Development
    • 12.13 SIEMENS
      • 12.13.1 SIEMENS Corporation Information
      • 12.13.2 SIEMENS Business Overview
      • 12.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.13.4 SIEMENS Radiopharmaceuticals Products Offered
      • 12.13.5 SIEMENS Recent Development
    • 12.14 Dongcheng
      • 12.14.1 Dongcheng Corporation Information
      • 12.14.2 Dongcheng Business Overview
      • 12.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.14.4 Dongcheng Radiopharmaceuticals Products Offered
      • 12.14.5 Dongcheng Recent Development
    • 12.15 Navidea
      • 12.15.1 Navidea Corporation Information
      • 12.15.2 Navidea Business Overview
      • 12.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
      • 12.15.4 Navidea Radiopharmaceuticals Products Offered
      • 12.15.5 Navidea Recent Development

    13 Radiopharmaceuticals Manufacturing Cost Analysis

    • 13.1 Radiopharmaceuticals Key Raw Materials Analysis
      • 13.1.1 Key Raw Materials
      • 13.1.2 Key Raw Materials Price Trend
      • 13.1.3 Key Suppliers of Raw Materials
    • 13.2 Proportion of Manufacturing Cost Structure
    • 13.3 Manufacturing Process Analysis of Radiopharmaceuticals
    • 13.4 Radiopharmaceuticals Industrial Chain Analysis

    14 Marketing Channel, Distributors and Customers

    • 14.1 Marketing Channel
    • 14.2 Radiopharmaceuticals Distributors List
    • 14.3 Radiopharmaceuticals Customers

    15 Market Dynamics

    • 15.1 Radiopharmaceuticals Market Trends
    • 15.2 Radiopharmaceuticals Drivers
    • 15.3 Radiopharmaceuticals Market Challenges
    • 15.4 Radiopharmaceuticals Market Restraints

    16 Research Findings and Conclusion

      17 Appendix

      • 17.1 Research Methodology
        • 17.1.1 Methodology/Research Approach
        • 17.1.2 Data Source
      • 17.2 Author List

      The global Radiopharmaceuticals market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Radiopharmaceuticals market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

      Segment by Type
      Diagnostic Radioisotopes
      Therapeutic Radioisotopes

      Segment by Application
      Oncology
      Cardiology
      Other

      The Radiopharmaceuticals market is analysed and market size information is provided by regions (countries). Segment by Application, the Radiopharmaceuticals market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

      By Company
      Bracco Imaging
      Bayer
      Mallinckrodt
      Nordion
      Triad Isotopes
      Lantheus
      IBA Group
      GE Healthcare
      China Isotope & Radiation
      Jubilant Pharma
      Eli Lilly
      Advanced Accelerator Applications
      SIEMENS
      Dongcheng
      Navidea



      Summary:
      Radiopharmaceuticals Market Research Report is about Radiopharmaceuticals Industry study. Get complete Radiopharmaceuticals market research report published after Market Study, Industrial Analysis with Trends & Statistics. Radiopharmaceuticals Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED

      Global Radiopharmaceuticals Sales Market Report 2021

      • 146 Pages
      • Region: Global
      $4,000.00

      Global Quartz Sales Market Report 2021

      • 147 Pages
      • Region: Global
      $4,000.00

      Global Bioplastics Sales Market Report 2021

      • 148 Pages
      • Region: Global
      $4,000.00

      Global Meglumine Sales Market Report 2021

      • 137 Pages
      • Region: Global
      $4,000.00

      Global Cystoscope Sales Market Report 2021

      • 138 Pages
      • Region: Global
      $4,000.00